JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2001; 38:1302-1306
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blake, G. J.
Right arrow Articles by Ridker, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blake, G. J.
Right arrow Articles by Ridker, P. M.

A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women

Gavin J. Blake, MB, MSc, MRCPI* {dagger} {ddagger} §, Nisha Dada, BS||, Jonathan C. Fox, MD, FACC, JoAnn E. Manson, MD, DrPH{dagger} and Paul M. Ridker, MD, MPH, FACC*,* {dagger} {ddagger} §

* Center for Cardiovascular Disease Prevention, Boston, Massachusetts, USA
{dagger} Division of Preventive Medicine, Boston, Massachusetts, USA
{ddagger} Division of Cardiovascular Disease, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
§ Leducq Center for Cardiovascular Research, Harvard Medical School, Boston, Massachusetts, USA
|| diaDexus, Inc., Santa Clara, California, USA
GlaxoSmithKlein, Philadelphia, Pennsylvania, USA



View larger version (20K):

[in a new window]
  		Figure 1 Adjusted relative risks of cardiovascular events according to increasing quartiles of lipoprotein-associated phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) compared to the lowest quartile. The error bars indicate the 95% CIs. The p values are for the highest quartile of plasma marker compared to the lowest quartile. These models were adjusted for random assignment to aspirin and vitamin E and for the following risk factors: low-density lipoprotein and high-density lipoprotein cholesterol, body mass index, a history of hypertension, a history of diabetes, a parental history of myocardial infarction, frequency of exercise and current use of hormone replacement therapy.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.